{
    "organizations": [],
    "uuid": "cd798e6b0ea8e7fc7674972dccb32ec620832c40",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nccn-guidelines-recommend-novocure/brief-nccn-guidelines-recommend-novocures-optune-in-combination-with-temozolomide-idUSFWN1R20NH",
    "ord_in_thread": 0,
    "title": "BRIEF-NCCN Guidelines Recommend Novocure's Optune In Combination With Temozolomide",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 4:34 PM / Updated 7 minutes ago BRIEF-NCCN Guidelines Recommend Novocure's Optune In Combination With Temozolomide Reuters Staff 1 Min Read March 20 (Reuters) - Novocure Ltd: * NCCN GUIDELINES RECOMMEND OPTUNE IN COMBINATION WITH TEMOZOLOMIDE AS A CATEGORY 1 TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA * NOVOCURE - ‚ÄçNCCN UPDATED CLINICAL PRACTICE GUIDELINES TO RECOMMEND OPTUNE IN COMBINATION WITH TEMOZOLOMIDE AS CATEGORY 1 TREATMENT FOR NEWLY DIAGNOSED GBM Source text for Eikon: Further company coverage:",
    "published": "2018-03-20T18:34:00.000+02:00",
    "crawled": "2018-03-20T18:47:26.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "guideline",
        "recommend",
        "novocure",
        "optune",
        "combination",
        "temozolomide",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "novocure",
        "ltd",
        "nccn",
        "guideline",
        "recommend",
        "optune",
        "combination",
        "temozolomide",
        "category",
        "treatment",
        "newly",
        "diagnosed",
        "glioblastoma",
        "novocure",
        "updated",
        "clinical",
        "practice",
        "guideline",
        "recommend",
        "optune",
        "combination",
        "temozolomide",
        "category",
        "treatment",
        "newly",
        "diagnosed",
        "gbm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}